Dr. Thomas Solbach is a Partner at Strategy& Germany, PwC’s strategy consulting business, based in Frankfurt. He leads the European commercial practice in pharma and life sciences and supports global pharmaceutical, biotech and healthcare companies in building game-changing, differentiating strategies and capabilities, as well as in the optimization of operating models. Thomas is a leading practitioner in precision medicine, patient-centered health ecosystems, innovative diagnostics and clinically relevant real-world evidence.

Dr. Thomas Solbach is a frequent speaker at healthcare conferences and author of several studies.

Prior to joining Strategy&, he conducted pharma-related research in the area of oncology and cardiovascular diseases. He completed his studies of Molecular Medicine at the University of Erlangen and the University of Oxford, and holds a PhD in the area of Health Economics.

Recent client work

• Precision medicine strategy and operating model (PharmaCo, MedTech, academia/ hospitals)
• Precision medicine ecosystem centered around patients across healthcare stakeholders
• Global real-world evidence strategy and operating model
• Integration of bio-/data-tech start-ups into big PharmaCo
• Post-merger integration for global PharmaCo
• Set-up of innovative global access strategy and operating model
• Customer excellence program
• Global launch excellence program
• Growth strategy for global PharmaCo
• Innovative commercial/Go-to-Market operating model for global PharmaCo